Evidence map›Paper›PMID 34779407›Full record

ArticleThe Journal of clinical investigation2021

LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy.

Pavlos Missios, Edroaldo Lummertz da Rocha, Daniel S Pearson, Julia Philipp, Maria M Aleman, Mehdi Pirouz, Dorian Farache, Joseph W Franses, Caroline Kubaczka, Kaloyan M Tsanov and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Pathogenesis of autoimmune disease.Nature reviews. Nephrology · 2023
    Review
  12. Article
  13. Review
  14. Metastasis in neuroblastoma: theFrontiers in oncology · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Pavlos MissiosStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Edroaldo Lummertz da RochaStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Daniel S PearsonStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Julia PhilippMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Maria M AlemanDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Mehdi PirouzStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Dorian FaracheDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Joseph W FransesMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
Caroline KubaczkaStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Kaloyan M TsanovStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Deepak K JhaStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Brian Pepe-MooneyStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
John T PowersStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Richard I GregoryStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Amy Sy LeeDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Daniel DominguezDepartment of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
David T TingMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
George Q DaleyStem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.
Boston Children's Hospital · USHarvard University · USUniversity of North Carolina at Chapel Hill · USRutgers, The State University of New Jersey · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Role of the Epitranscriptome in CancerR35CA232115 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREGORY, RICHARD I. · 2019 to 2025
$7.2M
Notice of Special Interest - R35 (Undergraduate Summer Funding)R35GM142527 · NIGMS · DANA-FARBER CANCER INST · PI LEE, AMY SI-YING · 2021 to 2025
$2.2M
Understanding the role of the lin28 paralogs and branching morphogenesisR01GM107536 · NIGMS · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q · 2014 to 2017
$1.9M
Role of noncoding RNA decay in glucose homeostasisK01DK121861 · NIDDK · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI PIROUZ, MEHDI · 2020 to 2021
$309k
Howard Hughes Medical InstituteNCI NIH HHS R35 CA232115NIDDK NIH HHS K01 DK121861NIGMS NIH HHS R01 GM107536NIGMS NIH HHS R35 GM142527NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

High expression of LIN28B is associated with aggressive malignancy and poor survival. Here, probing MYCN-amplified neuroblastoma as a model system, we showed that LIN28B expression was associated with enhanced cell migration in vitro and invasive and metastatic behavior in murine xenografts. Sequence analysis of the polyribosome fraction of LIN28B-expressing neuroblastoma cells revealed let-7-independent enrichment of transcripts encoding components of the translational and ribosomal apparatus and depletion of transcripts of neuronal developmental programs. We further observed that LIN28B utilizes both its cold shock and zinc finger RNA binding domains to preferentially interact with MYCN-induced transcripts of the ribosomal complex, enhancing their translation. These data demonstrated that LIN28B couples the MYCN-driven transcriptional program to enhanced ribosomal translation, thereby implicating LIN28B as a posttranscriptional driver of the metastatic phenotype.

Indexed as

Neoplasm MetastasisCell Line, TumorGene Expression Regulation, NeoplasticHumansNeuroblastomaN-Myc Proto-Oncogene ProteinRibosomesRNA-Binding ProteinsLIN28B protein, humanMYCN protein, humanN-Myc Proto-Oncogene ProteinRNA-Binding ProteinsCancerCell migration/adhesionOncologyTranslation

Identifiers

PMID34779407
PMCPMC8592552
OpenAlexW3211718957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.